While children under five, particularly those under two, are the most vulnerable, pneumococcal diseases also affect adults.

It may also be given to children 2 through 18 with medical conditions that increase their risk of pneumococcal disease. Pneumococcal vaccination in children significantly reduces invasive disease ...

Just one in four (25%) people at high risk of pneumococcal disease, an infection that causes pneumonia—children younger than 2, adults older than 64, and those with certain chronic health ...

The CDC revised its pneumococcal pneumonia shot recommendation, saying there is a substantial increase in the risk for ...

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to ...

Ensuring protection against pneumococcal disease requires monitoring of the ... is used in adults and children >2 years of age. By contrast, pneumococcal conjugate vaccines (PCVs) are currently ...